Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:CEO |
gptkb:Dr._Michael_R._Dyer
|
| gptkbp:collaboratesWith |
Pharmaceutical Companies
|
| gptkbp:focusArea |
Genomic Testing
|
| gptkbp:foundedIn |
2012
|
| gptkbp:hasAwards |
Best Places to Work
Best New Company Top 100 Healthcare Companies Excellence in Genomics Innovative_Technology_Award |
| gptkbp:hasClient |
Research Institutions
Hospitals Biopharmaceutical Companies |
| gptkbp:hasEmployees |
100-200
500+ 200-500 50-100 |
| gptkbp:hasFunding |
Venture_Capital_Firms
|
| gptkbp:hasOccupation |
Workshops
Webinars Patient Advocacy Groups Scientific Symposia Healthcare_Conferences |
| gptkbp:hasProductLine |
gptkb:OmniSeq_Target
gptkb:OmniSeq_Insight OmniSeq Immune |
| gptkbp:hasPublications |
Scientific Journals
|
| gptkbp:hasResearchFocus |
gptkb:Cancer_Genomics
Precision Medicine Biomarker_Discovery |
| gptkbp:hasSocialMediaPresence |
Facebook
|
| gptkbp:hasTechnology |
gptkb:Agilent_Technologies
gptkb:Thermo_Fisher_Scientific gptkb:Roche gptkb:Qiagen Illumina |
| gptkbp:headquarters |
gptkb:Buffalo,_New_York
|
| https://www.w3.org/2000/01/rdf-schema#label |
OmniSeq Insights
|
| gptkbp:offersServices |
Comprehensive Genomic Profiling
|
| gptkbp:participatesIn |
Clinical Trials
|
| gptkbp:partnerships |
Various Healthcare Institutions
|
| gptkbp:providesSupportFor |
Personalized Medicine
Researchers Pathologists Oncologists |
| gptkbp:targetMarket |
Oncology
|
| gptkbp:technology |
Next-Generation Sequencing
|
| gptkbp:website |
www.omniseq.com
|